Designs which allow each medical centre to treat only a limited number of cancer types with only a limited number of drugs
share
We consider designs for cancer trials which allow each medical centre to treat only a limited number of cancer types with only a limited number of drugs. We specify desirable properties of these designs, and prove some consequences. Then we give several different constructions. Finally we generalise this to three or more types of object, such as biomarkers.
READ FULL TEXT